Schering in triple UK agency appointment

Schering Health Care this week unveiled a trio of agency appointments as it cranks up comms activity across business fields ranging from contraception to diagnostic imaging.

The company is using Chandler Chicco Agency (CCA) for PR, medical education and advocacy across multiple sclerosis, contraception and andrology.

Santé Communications has been brought in to promote Bonefos, Schering’s treatment for the harmful effects of cancer in bones.

Nexus Communications, which is providing medical education support for Schering’s diagnostic imaging business, completes the agency troika.

CCA is handling all communications for Schering’s Betaferon multiple-sclerosis brand: just last week, the product received marketing authorisation from the European Commission for the first-line treatment of the earliest stages of multiple sclerosis.

The approval provides an important treatment option for patients to help cut the risk of developing clinically definite MS and the chance to delay its progression.

CCA, which has put a ten-strong team on its Schering business, is also handling health professional comms for the Yasmin and Mirena contraceptives. The agency is also working across Schering’s andrology portfolio, which includes the Nibido and Testogel brands.

Schering continues to use The Red Consultancy for consumer communications around contraception.

Schering Health Care is the UK subsidiary of German giant Schering, which is the subject of a takeover bid from Bayer.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in